UK Cystic Fibrosis Gene Therapy Consortium supports this campaign whole heartedly. All clinical trials should be registered and results published. “Negative” outcomes have as much scientific value as “positive” outcomes and publication of all data is necessary to progress translational research as quickly and safely as possible.
